{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T20:18:35Z","timestamp":1789935515886,"version":"4.0.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,11,18]],"date-time":"2017-11-18T00:00:00Z","timestamp":1510963200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00592-017-1065-z","type":"journal-article","created":{"date-parts":[[2017,11,18]],"date-time":"2017-11-18T04:26:16Z","timestamp":1510979176000},"page":"139-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The potential role of the osteopontin\u2013osteocalcin\u2013osteoprotegerin triad in the pathogenesis of prediabetes in humans"],"prefix":"10.1007","volume":"55","author":[{"given":"Giuseppe","family":"Daniele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidre","family":"Winnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bruder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Fourcaudot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuo","family":"Pengou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Hansis-Diarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Jenkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devjit","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Folli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,18]]},"reference":[{"key":"1065_CR1","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1517\/14656566.2014.944160","volume":"15","author":"G Daniele","year":"2014","unstructured":"Daniele G, Abdul-Ghani M, DeFronzo RA (2014) What are the pharmacotherapy options for treating prediabetes? Expert Opin Pharmacother 15:2003\u20132018","journal-title":"Expert Opin Pharmacother"},{"key":"1065_CR2","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.2337\/diabetes.50.6.1290","volume":"50","author":"M Federici","year":"2001","unstructured":"Federici M, Hribal M, Perego L et al (2001) High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 50:1290\u20131301","journal-title":"Diabetes"},{"key":"1065_CR3","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00125-009-1451-3","volume":"52","author":"A Monroy","year":"2009","unstructured":"Monroy A, Kamath S, Chavez AO et al (2009) Impaired regulation of the TNF-alpha converting enzyme\/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans. Diabetologia 52:2169\u20132181","journal-title":"Diabetologia"},{"key":"1065_CR4","doi-asserted-by":"crossref","first-page":"e28050","DOI":"10.1371\/journal.pone.0028050","volume":"6","author":"F Folli","year":"2011","unstructured":"Folli F, Okada T, Perego C et al (2011) Altered insulin receptor signalling and beta-cell cycle dynamics in type 2 diabetes mellitus. PLoS ONE 6:e28050","journal-title":"PLoS ONE"},{"key":"1065_CR5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00592-013-0543-1","volume":"51","author":"G Daniele","year":"2014","unstructured":"Daniele G, Guardado Mendoza R, Winnier D et al (2014) The inflammatory status score including IL-6, TNF-alpha, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus. Acta Diabetol 51:123\u2013131","journal-title":"Acta Diabetol"},{"key":"1065_CR6","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1007\/s00125-015-3625-5","volume":"58","author":"R Guardado Mendoza","year":"2015","unstructured":"Guardado Mendoza R, Perego C, Finzi G et al (2015) Delta cell death in the islet of Langerhans and the progression from normal glucose tolerance to type 2 diabetes in non-human primates (baboon, Papio hamadryas). Diabetologia 58:1814\u20131826","journal-title":"Diabetologia"},{"key":"1065_CR7","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2337\/diacare.28.3.668","volume":"28","author":"EB Schroeder","year":"2005","unstructured":"Schroeder EB, Chambless LE, Liao D et al (2005) Atherosclerosis risk in communities s: diabetes, glucose, insulin, and heart rate variability: the atherosclerosis risk in communities (ARIC) study. Diabetes Care 28:668\u2013674","journal-title":"Diabetes Care"},{"key":"1065_CR8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2215\/CJN.07891109","volume":"5","author":"LC Plantinga","year":"2010","unstructured":"Plantinga LC, Crews DC, Coresh J et al (2010) Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol 5:673\u2013682","journal-title":"Clin J Am Soc Nephrol"},{"key":"1065_CR9","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.2337\/dc10-1303","volume":"33","author":"S Tesfaye","year":"2010","unstructured":"Tesfaye S, Boulton AJ, Dyck PJ et al (2010) Toronto diabetic neuropathy expert G: diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33:2285\u20132293","journal-title":"Diabetes Care"},{"key":"1065_CR10","first-page":"1","volume":"124","author":"J Wei","year":"2014","unstructured":"Wei J, Ferron M, Clarke CJ et al (2014) Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J Clin Investig 124:1\u201313","journal-title":"J Clin Investig"},{"key":"1065_CR11","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/dc14-2989","volume":"38","author":"G Daniele","year":"2015","unstructured":"Daniele G, Winnier D, Mari A et al (2015) Sclerostin and insulin resistance in prediabetes: evidence of a cross talk between bone and glucose metabolism. Diabetes Care 38:1509\u20131517","journal-title":"Diabetes Care"},{"key":"1065_CR12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","volume":"130","author":"NK Lee","year":"2007","unstructured":"Lee NK, Sowa H, Hinoi E et al (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130:456\u2013469","journal-title":"Cell"},{"key":"1065_CR13","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1073\/pnas.0711119105","volume":"105","author":"M Ferron","year":"2008","unstructured":"Ferron M, Hinoi E, Karsenty G, Ducy P (2008) Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 105:5266\u20135270","journal-title":"Proc Natl Acad Sci USA"},{"key":"1065_CR14","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.2337\/db12-0976","volume":"62","author":"E Ahlqvist","year":"2013","unstructured":"Ahlqvist E, Osmark P, Kuulasmaa T et al (2013) Link between GIP and osteopontin in adipose tissue and insulin resistance. Diabetes 62:2088\u20132094","journal-title":"Diabetes"},{"key":"1065_CR15","first-page":"2355","volume":"85","author":"LC Hofbauer","year":"2000","unstructured":"Hofbauer LC, Heufelder AE (2000) Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases. J Clin Endocrinol Metab 85:2355\u20132363","journal-title":"J Clin Endocrinol Metab"},{"key":"1065_CR16","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1161\/ATVBAHA.112.300326","volume":"32","author":"AM Jansson","year":"2012","unstructured":"Jansson AM, Hartford M, Omland T et al (2012) Multimarker risk assessment including osteoprotegerin and CXCL16 in acute coronary syndromes. Arterioscler Thromb Vasc Biol 32:3041\u20133049","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1065_CR17","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","volume":"1","author":"RA DeFronzo","year":"2015","unstructured":"DeFronzo RA, Ferrannini E, Groop L et al (2015) Type 2 diabetes mellitus. Nat Rev Dis Primers 1:15019","journal-title":"Nat Rev Dis Primers"},{"key":"1065_CR18","first-page":"439","volume":"7","author":"B Roy","year":"2016","unstructured":"Roy B, Curtis ME, Fears LS, Nahashon SN, Fentress HM (2016) Molecular mechanisms of obesity-induced osteoporosis and muscle atrophy. Front Physiol 7:439","journal-title":"Front Physiol"},{"key":"1065_CR19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/diabetes.41.3.368","volume":"41","author":"E Cauter Van","year":"1992","unstructured":"Van Cauter E, Mestrez F, Sturis J, Polonsky KS (1992) Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368\u2013377","journal-title":"Diabetes"},{"key":"1065_CR20","doi-asserted-by":"crossref","first-page":"E1159","DOI":"10.1152\/ajpendo.00093.2002","volume":"283","author":"A Mari","year":"2002","unstructured":"Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E (2002) Meal and oral glucose tests for assessment of beta-cell function: modeling analysis in normal subjects. Am J Physiol Endocrinol Metab 283:E1159\u2013E1166","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1065_CR21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1749-6632.1959.tb44923.x","volume":"82","author":"R Steele","year":"1959","unstructured":"Steele R (1959) Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420\u2013430","journal-title":"Ann N Y Acad Sci"},{"key":"1065_CR22","doi-asserted-by":"crossref","unstructured":"Barchetta I, Alessandri C, Bertoccini L et al. (2015) Increased circulating osteopontin levels in adult patients with type 1 diabetes mellitus and association with dysmetabolic profile. Eur J Endocrinol\/European Federation of Endocrine Societies","DOI":"10.1530\/EJE-15-0791"},{"key":"1065_CR23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.atherosclerosis.2013.06.003","volume":"229","author":"AE Berezin","year":"2013","unstructured":"Berezin AE, Kremzer AA (2013) Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease. Atherosclerosis 229:475\u2013481","journal-title":"Atherosclerosis"},{"key":"1065_CR24","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1161\/ATVBAHA.110.204859","volume":"30","author":"U Saleem","year":"2010","unstructured":"Saleem U, Mosley TH Jr, Kullo IJ (2010) Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 30:1474\u20131478","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1065_CR25","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.cmet.2016.05.004","volume":"23","author":"P Mera","year":"2016","unstructured":"Mera P, Laue K, Ferron M et al (2016) Osteocalcin signaling in myofibers is necessary and sufficient for optimum adaptation to exercise. Cell Metab 23:1078\u20131092","journal-title":"Cell Metab"},{"key":"1065_CR26","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cmet.2016.04.011","volume":"23","author":"JH Stern","year":"2016","unstructured":"Stern JH, Rutkowski JM, Scherer PE (2016) Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk. Cell Metab 23:770\u2013784","journal-title":"Cell Metab"},{"key":"1065_CR27","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s00125-014-3273-1","volume":"57","author":"HM O\u2019Neill","year":"2014","unstructured":"O\u2019Neill HM, Lally JS, Galic S et al (2014) AMPK phosphorylation of ACC2 is required for skeletal muscle fatty acid oxidation and insulin sensitivity in mice. Diabetologia 57:1693\u20131702","journal-title":"Diabetologia"},{"key":"1065_CR28","doi-asserted-by":"crossref","first-page":"16381","DOI":"10.1073\/pnas.1113359108","volume":"108","author":"N Kumashiro","year":"2011","unstructured":"Kumashiro N, Erion DM, Zhang D et al (2011) Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Proc Natl Acad Sci USA 108:16381\u201316385","journal-title":"Proc Natl Acad Sci USA"},{"key":"1065_CR29","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/er.2008-0009","volume":"29","author":"N Stefan","year":"2008","unstructured":"Stefan N, Kantartzis K, Haring HU (2008) Causes and metabolic consequences of Fatty liver. Endocr Rev 29:939\u2013960","journal-title":"Endocr Rev"},{"key":"1065_CR30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.diabet.2016.02.004","volume":"42","author":"M Monseu","year":"2016","unstructured":"Monseu M, Dubois S, Boursier J et al (2016) Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults. Diabetes Metab 42:364\u2013367","journal-title":"Diabetes Metab"},{"key":"1065_CR31","doi-asserted-by":"crossref","first-page":"e97824","DOI":"10.1371\/journal.pone.0097824","volume":"9","author":"L Zhang","year":"2014","unstructured":"Zhang L, Meng S, Tu Q et al (2014) Adiponectin ameliorates experimental periodontitis in diet-induced obesity mice. PLoS ONE 9:e97824","journal-title":"PLoS ONE"},{"key":"1065_CR32","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1172\/JCI91578","volume":"126","author":"J Friedman","year":"2016","unstructured":"Friedman J (2016) The long road to leptin. J Clin Investig 126:4727\u20134734","journal-title":"J Clin Investig"},{"key":"1065_CR33","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1172\/JCI111765","volume":"75","author":"M Akmal","year":"1985","unstructured":"Akmal M, Massry SG, Goldstein DA, Fanti P, Weisz A, DeFronzo RA (1985) Role of parathyroid hormone in the glucose intolerance of chronic renal failure. J Clin Investig 75:1037\u20131044","journal-title":"J Clin Investig"},{"issue":"10","key":"1065_CR34","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1038\/oby.2010.11","volume":"18","author":"G Muscogiuri","year":"2010","unstructured":"Muscogiuri G, Sorice GP, Prioletta A et al (2010) 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 18(10):1906\u20131910","journal-title":"Obesity (Silver Spring)"},{"issue":"7","key":"1065_CR35","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2337\/dc16-2302","volume":"40","author":"HL Gulseth","year":"2017","unstructured":"Gulseth HL, Wium C, Angel K, Eriksen EF, Birkeland KI (2017) Effects of vitamin D supplementation on insulin sensitivity and insulin secretion in subjects with type 2 diabetes and vitamin d deficiency: a randomized controlled trial. Diabetes Care 40(7):872\u2013878","journal-title":"Diabetes Care"},{"issue":"2","key":"1065_CR36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11154-017-9423-2","volume":"18","author":"GS Garbossa","year":"2017","unstructured":"Garbossa GS, Folli F (2017) Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism. Rev Endocr Metab Disord 18(2):243\u2013258","journal-title":"Rev Endocr Metab Disord"},{"key":"1065_CR37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1520-6300(1999)11:2<167::AID-AJHB4>3.0.CO;2-G","volume":"11","author":"JP Clarys","year":"1999","unstructured":"Clarys JP, Martin AD, Marfell-Jones MJ, Janssens V, Caboor D, Drinkwater DT (1999) Human body composition: a review of adult dissection data. Am J Hum Biol 11:167\u2013174","journal-title":"Am J Hum Biol"},{"key":"1065_CR38","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1073\/pnas.1505071112","volume":"112","author":"AL Zihlman","year":"2015","unstructured":"Zihlman AL, Bolter DR (2015) Body composition in Pan paniscus compared with Homo sapiens has implications for changes during human evolution. Proc Natl Acad Sci USA 112:7466\u20137471","journal-title":"Proc Natl Acad Sci USA"},{"key":"1065_CR39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2011-2186","volume":"97","author":"A Garcia-Martin","year":"2012","unstructured":"Garcia-Martin A, Rozas-Moreno P, Reyes-Garcia R et al (2012) Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 97:234\u2013241","journal-title":"J Clin Endocrinol Metab"},{"key":"1065_CR40","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2016.02.043","volume":"164","author":"G Karsenty","year":"2016","unstructured":"Karsenty G, Olson EN (2016) Bone and muscle endocrine functions: unexpected paradigms of inter-organ communication. Cell 164:1248\u20131256","journal-title":"Cell"},{"key":"1065_CR41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/cen.13300","volume":"86","author":"OH Yu","year":"2017","unstructured":"Yu OH, Richards B, Berger C et al (2017) The association between sclerostin and incident type 2 diabetes risk: a cohort study. Clin Endocrinol 86:520\u2013525","journal-title":"Clin Endocrinol"},{"key":"1065_CR42","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2337\/db11-1300","volume":"61","author":"N Barzilai","year":"2012","unstructured":"Barzilai N, Huffman DM, Muzumdar RH, Bartke A (2012) The critical role of metabolic pathways in aging. Diabetes 61:1315\u20131322","journal-title":"Diabetes"},{"key":"1065_CR43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/MCO.0000000000000162","volume":"18","author":"RR Deer","year":"2015","unstructured":"Deer RR, Volpi E (2015) Protein intake and muscle function in older adults. Curr Opin Clin Nutr Metab care 18:248\u2013253","journal-title":"Curr Opin Clin Nutr Metab care"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00592-017-1065-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-017-1065-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-017-1065-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T09:23:44Z","timestamp":1570353824000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00592-017-1065-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,18]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["1065"],"URL":"https:\/\/doi.org\/10.1007\/s00592-017-1065-z","relation":{},"ISSN":["0940-5429","1432-5233"],"issn-type":[{"value":"0940-5429","type":"print"},{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,18]]}}}